Franklin G. Miller

Last updated

Franklin G. Miller (born 1948) [1] is an American bioethicist and senior faculty member at the National Institutes of Health (NIH). [2]

Contents

Education

Miller received his B.A. in philosophy in 1971 from Columbia College, Columbia University, and his PhD from Columbia University in 1977, also in philosophy. [3]

Career

From 1990 until 1998, Miller was a faculty member at the University of Virginia. [2] Since 1999, he has been a senior faculty member at the National Institutes of Health's department of bioethics, as well as a special expert at the NIH's Intramural Research Program. [3] [4] Since 2014, he has also been a professor of medical ethics by courtesy at Weill Cornell Medical College. [3]

Work

In 2008, Miller and Robert Truog co-authored a paper in the New England Journal of Medicine in which they questioned the dead donor rule, and proposed instead that living people should be able to donate vital organs so long as their brain was devastatingly damaged. [5] [6] In 2012, Miller co-authored a paper with Walter Sinnott-Armstrong in the Journal of Medical Ethics on whether killing was fundamentally wrong. [7] In the paper, Miller and Sinnott-Armstrong claimed that there was nothing fundamentally wrong with killing another person, and that it was only incidentally bad because it led to total disability. [8] In 2015, Miller and Ted Kaptchuk co-authored a perspective paper on placebo effects, again in the New England Journal of Medicine. [9] [10]

Related Research Articles

Hippocratic Oath Oath of ethics taken by physicians

The Hippocratic Oath is an oath of ethics historically taken by physicians. It is one of the most widely known of Greek medical texts. In its original form, it requires a new physician to swear, by a number of healing gods, to uphold specific ethical standards. The oath is the earliest expression of medical ethics in the Western world, establishing several principles of medical ethics which remain of paramount significance today. These include the principles of medical confidentiality and non-maleficence. As the seminal articulation of certain principles that continue to guide and inform medical practice, the ancient text is of more than historic and symbolic value. Swearing a modified form of the oath remains a rite of passage for medical graduates in many countries, and is a requirement enshrined in legal statutes of various jurisdictions, such that violations of the oath may carry criminal or other liability beyond the oath's symbolic nature.

Placebo Substance or treatment of no therapeutic value

A placebo is a sham substance or treatment which is designed to have no known therapeutic value. Common placebos include inert tablets, inert injections, sham surgery, and other procedures.

The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. It is among the most prestigious peer-reviewed medical journals as well as the oldest continuously published one.

Prior to the introduction of brain death into law in the mid to late 1970s, all organ transplants from cadaveric donors came from non-heart-beating donors (NHBDs).

A nocebo effect is said to occur when negative expectations of the patient regarding a treatment cause the treatment to have a more negative effect than it otherwise would have. For example, when a patient anticipates a side effect of a medication, they can experience that effect even if the "medication" is actually an inert substance. The complementary concept, the placebo effect, is said to occur when positive expectations improve an outcome. The effect is also said to occur in someone when they fall ill due to the erroneous belief that they were exposed to a toxin, or to a physical phenomenon they believe is harmful, such as EM radiation.

Drotrecogin alfa (activated) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with severe sepsis. The manufacturer's aggressive strategies in marketing its use in severe sepsis have been criticized. On October 25, 2011, Eli Lilly & Co. withdrew Xigris from the market after a major study showed no efficacy for the treatment of sepsis.

Medical research Wide array of research

Medical research, also known as experimental medicine, encompasses a wide array of research, extending from "basic research", – involving fundamental scientific principles that may apply to a preclinical understanding – to clinical research, which involves studies of people who may be subjects in clinical trials. Within this spectrum is applied research, or translational research, conducted to expand knowledge in the field of medicine.

John Roland Darsee is an American physician and former medical researcher. After compiling an impressive list of publications in reputable scientific journals, he was found to have fabricated data for his publications.

The Declaration of Helsinki is a set of ethical principles regarding human experimentation developed originally in 1964 for the medical community by the World Medical Association (WMA). It is widely regarded as the cornerstone document on human research ethics.

Henry K. Beecher American medical academic

Henry Knowles Beecher was a pioneering American anesthesiologist, medical ethicist, and investigator of the placebo effect at Harvard Medical School.

Ted Kaptchuk American medical academic

Ted Jack Kaptchuk is an American medical researcher who holds professorships in medicine and in global health and social medicine at Harvard Medical School. He researches the placebo effect within the field of placebo studies.

The word placebo was used in a medicinal context in the late 18th century to describe a "commonplace method or medicine" and in 1811 it was defined as "any medicine adapted more to please than to benefit the patient". Although this definition contained a derogatory implication, it did not necessarily imply that the remedy had no effect.

Terminal dehydration is dehydration to the point of death. Some scholars make a distinction between "terminal dehydration" and "termination by dehydration". Courts in the United States generally do not recognize prisoners as having a right to die by voluntary dehydration, since they view it as suicide.

Kamyar Kalantar-Zadeh is an Iranian-American physician doing research in nephrology, kidney dialysis, nutrition, and epidemiology. He is best known as a specialist in kidney disease nutrition and chronic kidney disease and for his hypothesis about the longevity of individuals with chronic disease states, also known as reverse epidemiology including obesity paradox. According to this hypothesis, obesity or hypercholesterolemia may counterintuitively be protective and associated with greater survival in certain groups of people, such as elderly individuals, dialysis patients, or those with chronic disease states and wasting syndrome (cachexia), whereas normal to low body mass index or normal values of serum cholesterol may be detrimental and associated with worse mortality. Kalantar-Zadeh is also known for his expertise in kidney dialysis therapy, including incremental dialysis, as well as renal nutrition. He is the brother of Kourosh Kalantar-zadeh, who an Australian scientist involved in research in the fields of materials sciences, nanotechnology, and transducers.

Amy Nadya Finkelstein is a professor of economics at the Massachusetts Institute of Technology (MIT), the co-director and research associate of the Public Economics Program at the National Bureau of Economic Research, and the co-Scientific Director of J-PAL North America. She was awarded the 2012 John Bates Clark Medal for her contributions to economics. She was elected to the National Academy of Sciences and won a MacArthur "Genius" fellowship in 2018.

Choosing Wisely U.S.-based educational campaign

Choosing Wisely is a United States-based health educational campaign, led by the ABIM Foundation, about unnecessary health care.

A physician-scientist is traditionally a holder of a medical degree and a doctor of philosophy also known as an MD-PhD. Compared to other clinicians, physician-scientists invest significant time and professional effort in scientific research and spend correspondingly less time in direct clinical practice with ratios of research to clinical time ranging from 50/50 to 80/20. Physician-scientists are often employed by academic or research institutions where they drive innovation across a wide range of medical specialties and may also use their extensive training to focus their clinical practices on specialized patient populations, such as those with rare genetic diseases or cancers. Although they are a minority of both practicing physicians and active research scientists, physician-scientists are often cited as playing a critical roles in translational medicine and clinical research by adapting biomedical research findings to health care applications. Overtime the term physician scientist has expanded to holders of other clinical degrees—such as nurses, dentists, and veterinarians— who are also included by the United States National Institutes of Health in its studies of the physician-scientist workforce (PSW).

Robert Truog American bioethicist and pediatrician

Robert D. Truog is an American bioethicist and pediatrician. He is the Frances Glessner Lee Professor of Medical Ethics, Anaesthesiology & Pediatrics at Harvard Medical School, where he is also the Director of the Center for Bioethics. He also practices in the pediatric intensive care unit at Boston Children’s Hospital, where he previously served as chair of the Division of Critical Care Medicine.

<i>The Oxford Textbook of Clinical Research Ethics</i>

The Oxford Textbook of Clinical Research Ethics is a textbook on clinical research ethics edited by Ezekiel Emanuel, Christine Grady, Robert A. Crouch, Reidar Lie, Franklin G. Miller and David Wendler.

Kathy Hudson American microbiologist

Kathy Lynn Hudson is an American microbiologist specializing in science policy. She was the deputy director for science, outreach, and policy at the National Institutes of Health from October 2010 to January 2017. Hudson assisted in the creation and launch of All of Us, the BRAIN initiative, and the National Center for Advancing Translational Sciences. She founded the Genetics and Public Policy Center at Johns Hopkins University in 2002. Hudson is an advocate for women in science.

References

  1. ↑ "Franklin G. Miller". Library of Congress. Retrieved 19 August 2015.
  2. 1 2 "Franklin Miller, PhD". NIH website. Retrieved 19 August 2015.
  3. 1 2 3 "Franklin G. Miller, PhD Curriculum Vitae" (PDF). NIH. Retrieved 19 August 2015.
  4. ↑ Kupferschmidt, K. (24 May 2011). "More placebo use promoted in Germany". Canadian Medical Association Journal. 183 (10): E633–E634. doi:10.1503/cmaj.109-3895. PMC   3134747 . PMID   21609985.
  5. ↑ Truog, Robert D.; Miller, Franklin G. (14 August 2008). "The Dead Donor Rule and Organ Transplantation". New England Journal of Medicine. 359 (7): 674–675. doi:10.1056/NEJMp0804474. PMID   18703469.
  6. ↑ "O death, when is thy sting?". The Economist. 2 October 2008. Retrieved 19 August 2015.
  7. ↑ Sinnott-Armstrong, W.; Miller, F. G. (19 January 2012). "What makes killing wrong?". Journal of Medical Ethics. 39 (1): 3–7. doi: 10.1136/medethics-2011-100351 . PMID   22267342.
  8. ↑ Rothman, Josh (4 February 2012). "Is Killing Wrong?". Boston.com. Retrieved 19 August 2015.
  9. ↑ Kaptchuk, Ted J.; Miller, Franklin G. (2 July 2015). "Placebo Effects in Medicine". New England Journal of Medicine. 373 (1): 8–9. doi:10.1056/NEJMp1504023.
  10. ↑ Houston, Muiris (20 July 2015). "Medical Matters: How empathy and engagement enhance the placebo effect". Irish Times. Retrieved 19 August 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.